• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Cardiac Prosthetic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Cardiac Prosthetic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • ID: 2711740
  • November 2013
  • Region: Global
  • 80 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Abiomed, Inc
  • AtriCure, Inc
  • Medtronic, Inc
  • Siemens Healthcare
  • Sorin Group
  • MORE

'Cardiac Prosthetic Devices Market (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter Heart Valves, Implantable Pacemaker and External Pacemaker) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

Cardiac prosthetics or the artificial heart valves are the devices used for replacing damaged or diseased natural valves of the heart. Human heart might be considered as a pump for supporting the pulmonary and systemic blood circulation. Heart comprises of receiving and pumping chamber, coupled with two valves for ensuring the unidirectional flow of blood.

Sometimes pathological diseases such as diabetes, obesity, hypertension and others might hamper the working mechanism of the valves. Hence, cardiac prosthetics are designed to replace the diseased or damaged natural valves. Artificial valves mainly are of two types namely mechanical heart valves and biological heart valves. Mechanical valves are made up of synthetic materials such as polymers, ceramics and metals. Biologic or the tissue valves are made up of materials from biological origin after modification using physico-chemical treatments.

Cardiac diseases are the most READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • Abiomed, Inc
  • AtriCure, Inc
  • Medtronic, Inc
  • Siemens Healthcare
  • Sorin Group
  • MORE

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research

Chapter 2 Executive Summary
2.1 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising Geriatric Population
3.2.2 Rising Prevalence of Disorders such as Hypertension, Diabetes and Obesity
3.2.3 Increasing Demand for Minimally-Invasive Procedures
3.3 Market Restraints
3.3.1 Implementation of Affordable Healthcare Act
3.3.2 Strict Approval Process from Government Bodies
3.4 Market Opportunities
3.4.1 Big Opportunities in Emerging Economies with High Unmet Needs
3.4.2 Huge Scope for Alliance with Organizations having Complementary Strength
3.5 Porter’s Five Forces Analysis for the Global Cardiac Prosthetic Devices Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis for the Global Cardiac Prosthetic Devices Market, by Geography
3.7 Market Share by Key Players of Global Cardiac Prosthetic Devices Market, 2012
3.7.1 Global Cardiac Prosthetic Devices Market Share, by Key Players, 2012 (%)

Chapter 4 Cardiac Prosthetic Devices Market, by Segments
4.1 Overview
4.1.1 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
4.2 Heart Valves
4.2.1 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
4.2.2 Mechanical Heart Valves
4.2.2.1 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
4.2.3 Tissue Heart Valves
4.2.3.1 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
4.2.3.2 Stented Tissue Valve
4.2.3.2.1 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
4.2.3.1 Stentless Tissue Valve
4.2.3.1.1 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
4.2.4 Transcatheter Heart Valves
4.2.4.1 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
4.3 Pacemaker
4.3.1 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
4.3.2 Implantable Pacemaker
4.3.3 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
4.3.3.1 Single-Chamber Battery Pacemaker
4.3.3.1.1 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
4.3.3.2 Dual-Chamber Battery Pacemaker
4.3.3.2.1 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
4.3.3.3 Triple-Chamber Battery Pacemaker
4.3.3.3.1 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
4.3.4 External Pacemaker
4.3.4.1 Global External Pacemaker Market, 2011 – 2019 (USD Million)

Chapter 5 Cardiac Prosthetic Devices Market, by Geography
5.1 Overview
5.1.1 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.2 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
5.3 North America
5.3.1 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.4 Europe
5.4.1 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.5 Asia-Pacific
5.5.1 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.6 Rest of the World (RoW)
5.6.1 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

Chapter 6 Recommendations
6.1 Market Strategies for Success
6.2 Barriers to be Considered

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Abiomed, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 AtriCure, Inc.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Edward Lifesciences Corporation
7.5.1 Company overview
7.5.2 Financial overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Medtronic, Inc.
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Siemens Healthcare
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Sorin Group
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 St. Jude Medical, Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments

ist of Figures

FIG. 1 Cardiac Prosthetic Devices: Market Segmentation
FIG. 2 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)
FIG. 3 Porter’s Five Forces Analysis: Cardiac Prosthetic Devices Market
FIG. 4 Market Attractiveness Analysis: Global Cardiac Prosthetic Devices Market, by Geography
FIG. 5 Cardiac Prosthetic Devices: Market Share, by Key Players, 2012 (%)
FIG. 6 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
FIG. 7 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
FIG. 8 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
FIG. 9 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
FIG. 10 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 11 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 12 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 13 Global External Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 14 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
FIG. 15 Abbott Laboratories, Annual Revenue: 2010 – 2012 (USD Billion)
FIG. 16 Abiomed, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 17 AtriCure, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 18 Boston Scientific Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Edward Lifesciences Corporation, Net Sales: 2010 – 2012 (USD Billion)
FIG. 20 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Sorin Group, Net Sales: 2010 – 2012 (USD Million)
FIG. 23 St. Jude Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Cardiac Prosthetic Devices Market (2012 & 2019)
TABLE 2 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
TABLE 3 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 4 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 7 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 8 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 9 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 11 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

- Abbott Laboratories
- Abiomed, Inc
- AtriCure, Inc
- Boston Scientific Corporation
- Edward Lifesciences Corporation
- Medtronic, Inc
- Siemens Healthcare
- Sorin Group
- St Jude Medical, Inc

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos